XFOR - X4 Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/2016
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development19,64616,22312,761
Selling General and Administrative9,4396,0245,126
Non Recurring---
Others---
Total Operating Expenses29,08522,24717,887
Operating Income or Loss-29,085-22,247-17,887
Income from Continuing Operations
Total Other Income/Expenses Net-4,20025322
Earnings Before Interest and Taxes-29,085-22,247-17,887
Interest Expense-720-490-53
Income Before Tax-33,285-21,994-17,865
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-33,285-21,994-17,865
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-33,285-21,994-17,865
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-36,307-24,994-20,873